promegestone has been researched along with sirolimus in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baulieu, EE; Le Bihan, S; Mader, S; Marsaud, V; Mercier-Bodard, C; Renoir, JM; White, JH | 1 |
Faber, LE; Pang, H | 1 |
2 other study(ies) available for promegestone and sirolimus
Article | Year |
---|---|
Calcium/calmodulin kinase inhibitors and immunosuppressant macrolides rapamycin and FK506 inhibit progestin- and glucocorticosteroid receptor-mediated transcription in human breast cancer T47D cells.
Topics: Animals; Breast Neoplasms; Calcium-Calmodulin-Dependent Protein Kinases; Chloramphenicol O-Acetyltransferase; Enzyme Inhibitors; HSP70 Heat-Shock Proteins; HSP90 Heat-Shock Proteins; Humans; Immunosuppressive Agents; Macromolecular Substances; Mice; Polyenes; Promegestone; Receptors, Glucocorticoid; Receptors, Progesterone; RNA, Messenger; Sirolimus; Tacrolimus; Transcription, Genetic; Triamcinolone Acetonide; Tumor Cells, Cultured | 1998 |
Estrogen and rapamycin effects on cell cycle progression in T47D breast cancer cells.
Topics: Antibiotics, Antineoplastic; Breast Neoplasms; Cell Division; Estradiol; Female; Humans; In Vitro Techniques; Promegestone; Receptors, Estrogen; S Phase; Sirolimus; Tumor Cells, Cultured | 2001 |